The following section provides information on Evotec SE’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Evotec SE's management and employees, unlock the full data with our company analytics monitoring tool.
Dr. Werner Lanthaler has been the Chief Executive Officer of the company since 2009. Prior to this, he served as the Chief Financial Officer at Intercell AG. From 1998 to 2001, Mr. Lanthaler served as a Director of the Federation of Austrian Industry. He was the Senior Management Consultant at the consulting firm McKinsey & Company from 1995 to 1998.
Mr. Enno Spillner has been the Chief Financial Officer of the company since 2016. Prior to this, he was the Chairman, Chief Executive Officer and Chief Financial Officer of 4SC AG. Mr. Spillner also served as the Head of Finance and Controlling at BioM AG.
Dr. Craig Johnstone has been the Chief Operating Officer of the company since January 2019. Previously, he served as the Global Head, Integrated drug discovery of Evotec (France) SAS from January 2017; as Directeur General and Site head for Evotec (France) SAS from April 2015. Prior to this, he served as the Senior Vice President, Drug Discovery and Innovation Efficiency of the company since May 2012. From 1994 to 2012, he served in several leadership positions at AstraZeneca, Prosidion and Rapier research.
Dr. Cord Dohrmann has been the Chief Scientific Officer of the company since 2010. He also serves on the German Council of Science and Humanities. Mr. Dohrmann has also been advising the European Commission, the Max Planck Institute and venture capital firms and authored and co-authored a number of publications and patents. He has spent over 20 years in biomedical research at leading academic institutions and in the biotech industry.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer